Xin Pan

4.7k total citations · 1 hit paper
71 papers, 3.0k citations indexed

About

Xin Pan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xin Pan has authored 71 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 17 papers in Cancer Research and 14 papers in Oncology. Recurrent topics in Xin Pan's work include Mitochondrial Function and Pathology (12 papers), Ubiquitin and proteasome pathways (11 papers) and ATP Synthase and ATPases Research (8 papers). Xin Pan is often cited by papers focused on Mitochondrial Function and Pathology (12 papers), Ubiquitin and proteasome pathways (11 papers) and ATP Synthase and ATPases Research (8 papers). Xin Pan collaborates with scholars based in China, United States and Switzerland. Xin Pan's co-authors include Toren Finkel, Elizabeth Murphy, Junhui Sun, Tao Zhou, Tiffany Nguyen, Ailing Li, Kira M. Holmström, Huiyan Li, Danielle Springer and Marı́a M. Fergusson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Xin Pan

66 papers receiving 3.0k citations

Hit Papers

The physiological role of mitochondrial calcium revealed ... 2013 2026 2017 2021 2013 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xin Pan China 27 2.3k 722 304 284 266 71 3.0k
Payaningal R. Somanath United States 39 2.3k 1.0× 806 1.1× 241 0.8× 620 2.2× 213 0.8× 124 4.3k
Serge Hardy Canada 27 1.9k 0.8× 387 0.5× 268 0.9× 244 0.9× 207 0.8× 53 2.8k
Jenny Z. Zheng United States 20 2.1k 0.9× 1.1k 1.6× 239 0.8× 385 1.4× 173 0.7× 23 3.2k
Mi‐Ae Yoo South Korea 28 1.9k 0.8× 631 0.9× 344 1.1× 413 1.5× 375 1.4× 73 3.2k
Qiming J. Wang United States 31 2.4k 1.1× 691 1.0× 252 0.8× 577 2.0× 210 0.8× 76 3.5k
Xiaojun Zhu China 25 1.9k 0.8× 292 0.4× 246 0.8× 204 0.7× 212 0.8× 58 2.5k
Fei Chen China 30 1.9k 0.8× 472 0.7× 224 0.7× 521 1.8× 415 1.6× 114 3.3k
Katherine T. Landschulz United States 13 1.3k 0.6× 536 0.7× 263 0.9× 477 1.7× 393 1.5× 17 3.3k
Noriaki Shimizu Japan 33 2.7k 1.2× 928 1.3× 402 1.3× 396 1.4× 188 0.7× 85 3.8k
Fei Xiao China 33 1.3k 0.5× 498 0.7× 350 1.2× 220 0.8× 341 1.3× 92 2.6k

Countries citing papers authored by Xin Pan

Since Specialization
Citations

This map shows the geographic impact of Xin Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Pan more than expected).

Fields of papers citing papers by Xin Pan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xin Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Pan. The network helps show where Xin Pan may publish in the future.

Co-authorship network of co-authors of Xin Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Xin Pan. A scholar is included among the top collaborators of Xin Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xin Pan. Xin Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gan, Lu, Xiaona Lin, Yichun Zheng, et al.. (2025). Ferroptosis meets cancer immunotherapy: Overcoming the crosstalk challenges through advanced drug delivery strategies. Acta Pharmaceutica Sinica B. 15(12). 6307–6341.
2.
Wu, Zhenghao, Peng Zheng, Xin Pan, et al.. (2025). Targeted Degradation of sGRP78 Alleviates the Immunosuppressive Tumor Microenvironment. Advanced Science. 12(45). e09921–e09921.
3.
4.
Xu, Zhisheng, Tingting Fu, Qiqi Guo, et al.. (2022). Disuse-associated loss of the protease LONP1 in muscle impairs mitochondrial function and causes reduced skeletal muscle mass and strength. Nature Communications. 13(1). 894–894. 62 indexed citations
5.
Pan, Xin, et al.. (2020). Identification of Hub Genes in Atypical Teratoid/Rhabdoid Tumor by Bioinformatics Analyses. Journal of Molecular Neuroscience. 70(11). 1906–1913. 9 indexed citations
6.
Liu, Wei, Yi Chai, Junhua Wang, et al.. (2020). <p>Polyphyllin VI Induces Apoptosis and Autophagy via Reactive Oxygen Species Mediated JNK and P38 Activation in Glioma</p>. OncoTargets and Therapy. Volume 13. 2275–2288. 25 indexed citations
7.
Pan, Xin, et al.. (2018). LINC01016 promotes the malignant phenotype of endometrial cancer cells by regulating the miR-302a-3p/miR-3130-3p/NFYA/SATB1 axis. Cell Death and Disease. 9(3). 303–303. 50 indexed citations
8.
Zhong, Xiuying, Peng Cui, Yongping Cai, et al.. (2018). Mitochondrial Dynamics Is Critical for the Full Pluripotency and Embryonic Developmental Potential of Pluripotent Stem Cells. Cell Metabolism. 29(4). 979–992.e4. 71 indexed citations
9.
Zhang, Shaoheng, et al.. (2017). HIF-2α and Oct4 have synergistic effects on survival and myocardial repair of very small embryonic-like mesenchymal stem cells in infarcted hearts. Cell Death and Disease. 8(1). e2548–e2548. 36 indexed citations
10.
Sun, Linchong, Libing Song, Qianfen Wan, et al.. (2015). cMyc-mediated activation of serine biosynthesis pathway is critical for cancer progression under nutrient deprivation conditions. Cell Research. 25(4). 429–444. 239 indexed citations
12.
Zhang, Hai‐Ying, Bin Liang, Tao Zhou, et al.. (2010). Tumor-targeted delivery of biologically active TRAIL protein. Cancer Gene Therapy. 17(5). 334–343. 38 indexed citations
13.
Zeng, Lingyu, et al.. (2008). Irradiation Is an Early Determinant of Endothelial Injury During Hematopoietic Stem Cell Transplantation. Transplantation Proceedings. 40(8). 2661–2664. 15 indexed citations
14.
Zhang, Peijing, Jie Zhao, Huiyan Li, et al.. (2007). CUE domain containing 2 regulates degradation of progesterone receptor by ubiquitin–proteasome. The EMBO Journal. 26(7). 1831–1842. 60 indexed citations
15.
Pan, Xin, Huiyan Li, Peijing Zhang, et al.. (2006). Ubc9 interacts with SOX4 and represses its transcriptional activity. Biochemical and Biophysical Research Communications. 344(3). 727–734. 24 indexed citations
16.
Man, Jiang-Hong, Huiyan Li, Peijing Zhang, et al.. (2006). PIAS3 induction of PRB sumoylation represses PRB transactivation by destabilizing its retention in the nucleus. Nucleic Acids Research. 34(19). 5552–5566. 28 indexed citations
17.
Pan, Xin. (2004). Effects of endostatin-vascular endothelial growth inhibitor chimeric recombinant adenoviruses on antiangiogenesis. World Journal of Gastroenterology. 10(10). 1409–1409. 22 indexed citations
18.
Li, Ai-Ling, Huiyan Li, Tao Zhou, et al.. (2004). A Novel eIF5A Complex Functions As a Regulator of p53 and p53-dependent Apoptosis. Journal of Biological Chemistry. 279(47). 49251–49258. 111 indexed citations
19.
Cao, Mingmei, Hao Ren, Xin Pan, Wei Pan, & Zhongtian Qi. (2004). Inhibition of EGFP expression by siRNA in EGFP-stably expressing Huh-7 cells. Journal of Virological Methods. 119(2). 189–194. 23 indexed citations
20.
Cao, Guangwen, Shigeki Kuriyama, Long Cui, et al.. (1999). Analysis of the human carcinoembryonic antigen promoter core region in colorectal carcinoma-selective cytosine deaminase gene therapy. Cancer Gene Therapy. 6(6). 572–580. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026